Residency · Norfolk, VA
Sponsored by Old Dominion University
International consensus statement on allergy and rhinology: rhinosinusitis 2021.
International forum of allergy & rhinology · 2021 · 768 citations · Joseph Han
EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023.
Rhinology · 2023 · 298 citations · Joseph Han
Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps.
The New England journal of medicine · 2025 · 154 citations · Joseph Han
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial.
The Lancet. Respiratory medicine · 2021 · 531 citations · Joseph Han
Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial.
The Journal of allergy and clinical immunology · 2022 · 270 citations · Joseph Han
Efficacy and safety of twice per year depemokimab in chronic rhinosinusitis with nasal polyps (ANCHOR-1 and ANCHOR-2): phase 3, randomised, double-blind, parallel trials.
Lancet (London, England) · 2025 · 76 citations · Joseph Han
EPOS2020/EUFOREA expert opinion on defining disease states and therapeutic goals in CRSwNP.
Rhinology · 2024 · 110 citations · Joseph Han
Adenotonsillectomy for Snoring and Mild Sleep Apnea in Children: A Randomized Clinical Trial.
JAMA · 2023 · 97 citations · Cristina Baldassari